Said J, Trybala E, Gorander S, Ekblad M, Liljeqvist J, Jennische E
Antimicrob Agents Chemother. 2015; 60(2):1049-57.
PMID: 26643323
PMC: 4750709.
DOI: 10.1128/AAC.02132-15.
Gordts S, Ferir G, Dhuys T, Petrova M, Lebeer S, Snoeck R
PLoS One. 2015; 10(7):e0131219.
PMID: 26132818
PMC: 4488490.
DOI: 10.1371/journal.pone.0131219.
Shankar G, Alt C
J Antimicrob Chemother. 2014; 69(12):3282-93.
PMID: 25139839
PMC: 4228782.
DOI: 10.1093/jac/dku318.
Tan S, Lu L, Li L, Liu J, Oksov Y, Lu H
PLoS One. 2013; 8(3):e59777.
PMID: 23544097
PMC: 3609764.
DOI: 10.1371/journal.pone.0059777.
Majid A, Redfield R, Gilliam B
HIV AIDS (Auckl). 2012; 4:17-28.
PMID: 22347807
PMC: 3280625.
DOI: 10.2147/HIV.S25082.
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.
McCormack S, Ramjee G, Kamali A, Rees H, Crook A, Gafos M
Lancet. 2010; 376(9749):1329-37.
PMID: 20851460
PMC: 2956883.
DOI: 10.1016/S0140-6736(10)61086-0.
Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.
Olsen J, Brown C, Capule C, Rubinshtein M, Doran T, Srivastava R
J Biol Chem. 2010; 285(46):35488-96.
PMID: 20833717
PMC: 2975173.
DOI: 10.1074/jbc.M110.163659.
Development of topical microbicides to prevent the sexual transmission of HIV.
Buckheit Jr R, Watson K, Morrow K, Ham A
Antiviral Res. 2009; 85(1):142-58.
PMID: 19874851
PMC: 2815091.
DOI: 10.1016/j.antiviral.2009.10.013.
Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection.
Blanco J, Pletneva L, Wieczorek L, Khetawat D, Stantchev T, Broder C
Virol J. 2009; 6:57.
PMID: 19442298
PMC: 2689193.
DOI: 10.1186/1743-422X-6-57.
Vaginal drug delivery systems for HIV prevention.
Rohan L, Sassi A
AAPS J. 2009; 11(1):78-87.
PMID: 19194802
PMC: 2664883.
DOI: 10.1208/s12248-009-9082-7.
A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections.
Ndesendo V, Pillay V, Choonara Y, Buchmann E, Bayever D, Meyer L
AAPS PharmSciTech. 2008; 9(2):505-20.
PMID: 18431651
PMC: 2976928.
DOI: 10.1208/s12249-008-9073-5.
NIAID resources for developing new therapies for severe viral infections.
Greenstone H, Spinelli B, Tseng C, Peacock S, Taylor K, Laughlin C
Antiviral Res. 2007; 78(1):51-9.
PMID: 18061283
PMC: 7132394.
DOI: 10.1016/j.antiviral.2007.10.006.
Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission.
Cone R, Hoen T, Wong X, Abusuwwa R, Anderson D, Moench T
BMC Infect Dis. 2006; 6:90.
PMID: 16740164
PMC: 1523343.
DOI: 10.1186/1471-2334-6-90.
Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India.
Smita J, Soma D, Beverly B, Albert P, JoAnn K, Fang G
AIDS Res Ther. 2006; 3:4.
PMID: 16504023
PMC: 1435917.
DOI: 10.1186/1742-6405-3-4.
The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies.
Yim K, Carroll C, Tuyama A, Cheshenko N, Carlucci M, Porter D
J Virol. 2005; 79(23):14632-9.
PMID: 16282463
PMC: 1287570.
DOI: 10.1128/JVI.79.23.14632-14639.2005.
Vaginal microbicides: a novel approach to preventing sexual transmission of HIV.
Doncel G, Mauck C
Curr HIV/AIDS Rep. 2005; 1(1):25-32.
PMID: 16091220
DOI: 10.1007/s11904-004-0004-0.
Efficacy and toxicity of zinc salts as candidate topical microbicides against vaginal herpes simplex virus type 2 infection.
Bourne N, Stegall R, Montano R, Meador M, Stanberry L, Milligan G
Antimicrob Agents Chemother. 2005; 49(3):1181-3.
PMID: 15728922
PMC: 549274.
DOI: 10.1128/AAC.49.3.1181-1183.2005.
Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.
Cheshenko N, Keller M, MasCasullo V, Jarvis G, Cheng H, John M
Antimicrob Agents Chemother. 2004; 48(6):2025-36.
PMID: 15155195
PMC: 415621.
DOI: 10.1128/AAC.48.6.2025-2036.2004.
Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes.
Bernstein D, Stanberry L, Sacks S, Ayisi N, Gong Y, Ireland J
Antimicrob Agents Chemother. 2003; 47(12):3784-8.
PMID: 14638483
PMC: 296200.
DOI: 10.1128/AAC.47.12.3784-3788.2003.
Therapeutic Options for Herpes Simplex Infections.
Au E, Sacks S
Curr Infect Dis Rep. 2003; 5(1):22-27.
PMID: 12525287
DOI: 10.1007/s11908-003-0061-3.